User profiles for Yasushi Yatabe

Y. YATABE

Verified email at ncc.go.jp
Cited by 74563

[HTML][HTML] International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of …

…, AG Nicholson, KR Geisinger, Y Yatabe… - Journal of thoracic …, 2011 - Elsevier
Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …

Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer: Biological and Clinical Implications

T Kosaka, Y Yatabe, H Endoh, H Kuwano, T Takahashi… - Cancer research, 2004 - AACR
Recently it has been reported that mutations in the tyrosine kinase domain of the epidermal
growth factor receptor(EGFR) gene occur in a subset of patients with lung cancer showing a …

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non–small-cell lung cancer with …

…, M Shinoda, T Takahashi, Y Yatabe - Journal of Clinical …, 2005 - ascopubs.org
Purpose To evaluate the relationship between mutations of the epidermal growth factor
receptor (EGFR) gene and the effectiveness of gefitinib treatment in patients with recurrent lung …

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an …

T Mitsudomi, S Morita, Y Yatabe, S Negoro… - The lancet …, 2010 - thelancet.com
Background Patients with non-small-cell lung cancer harbouring mutations in the epidermal
growth factor receptor (EGFR) gene respond well to the EGFR-specific tyrosine kinase …

Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

…, S Tomida, H Osada, H Endoh, T Harano, Y Yatabe… - Cancer research, 2004 - AACR
In this study, we report for the first time reduced expression of the let-7 microRNA in human
lung cancers. Interestingly, 143 lung cancer cases that had undergone potentially curative …

Comprehensive genomic profiles of small cell lung cancer

…, S Ansén, M Hallek, J Wolf, M Vingron, Y Yatabe… - Nature, 2015 - nature.com
We have sequenced the genomes of 110 small cell lung cancers (SCLC), one of the deadliest
human cancers. In nearly all the tumours analysed we found bi-allelic inactivation of TP53 …

Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib

T Kosaka, Y Yatabe, H Endoh, K Yoshida, T Hida… - Clinical Cancer …, 2006 - AACR
Purpose: Non–small cell lung cancers carrying activating mutations in the gene for the
epidermal growth factor receptor (EGFR) are highly sensitive to EGFR-specific tyrosine kinase …

[HTML][HTML] The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification

WD Travis, E Brambilla, AG Nicholson, Y Yatabe… - Journal of thoracic …, 2015 - Elsevier
The 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura,
Thymus and Heart has just been published with numerous important changes from the 2004 …

A Polycistronic MicroRNA Cluster, miR-17-92, Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation

…, H Yamada, K Yanagisawa, S Tomida, Y Yatabe… - Cancer research, 2005 - AACR
MicroRNAs (miRNAs) are small noncoding RNAs, thought to be involved in physiologic and
developmental processes by negatively regulating expression of target genes. We have …

[HTML][HTML] EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors

…, J Takashima, T Nakajima, Y Yatabe… - … England Journal of …, 2010 - Mass Medical Soc
<p id="p001">The EML4 (echinoderm microtubule-associated protein-like 4)–ALK (anaplastic
lymphoma kinase) fusion-type tyrosine kinase is an oncoprotein found in 4 to 5% of non–…